See up to 3 months of STE. The 7-day demo opens the 1M and 3M ranges and puts STE on your watchlist.
Start 7-day demoLatest STE insider trades
Mohsen Sohi - DirectorOpen-market sale$957K
John Adam Zangerle - OfficerOpen-market sale$297K
About STERIS plc (STE)
STERIS plc is an SEC registrant, filing under CIK 0001757898, classified as orthopedic, prosthetic and surgical appliances and supplies. It is grouped with Health Care companies on this site.
STE Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 1 | 4,058 | $957K |
| Grant or award | 13 | 13,475 | |
| Option exercise | 2 | 8,116 | |
STE insider transactions (Form 4)
3378 Form 4 filings on record, the earliest from Oct 2, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Cynthia L. Feldmann - Director | Option exercise | Ordinary Shares | 3,495 | $0.00 | - | |
| Cynthia L. Feldmann - Director | Open-market sale | Ordinary Shares | 3,495 | $241.56 | $844K | |
| Cynthia L. Feldmann - Director | Grant or award | Director Stock Option (right to buy) | 1,407 | $0.00 | - | |
| Cynthia L. Feldmann - Director | Grant or award | Career Restricted Stock Units | 487 | $0.00 | - | |
| Cynthia L. Feldmann - Director | Option exercise | Director Stock Option (right to buy) | 3,495 | $0.00 | - | |
 Karen L. Burton - Officer | Option exercise | Ordinary Shares | 7,900 | $114.22 | $902K | |
| Karen L. Burton - Officer | Open-market sale | Ordinary Shares | 7,900 | $241.73 | $1.91M | |
| Karen L. Burton - Officer | Option exercise | Employee Stock Option (right to buy) | 7,900 | $0.00 | - | |
 Louis Shapiro - Director | Grant or award | Career Restricted Stock Units | 975 | $0.00 | - | |
| Esther M. Alegria - Director | Grant or award | Director Stock Option (right to buy) | 1,407 | $0.00 | - | |
| Esther M. Alegria - Director | Grant or award | Career Restricted Stock Units | 487 | $0.00 | - | |
| Nirav R. Shah - Director | Grant or award | Director Stock Option (right to buy) | 1,407 | $0.00 | - | |
| Nirav R. Shah - Director | Grant or award | Career Restricted Stock Units | 487 | $0.00 | - | |
| Paul Edward Martin - Director | Grant or award | Director Stock Option (right to buy) | 1,407 | $0.00 | - | |
| Paul Edward Martin - Director | Grant or award | Career Restricted Stock Units | 487 | $0.00 | - | |
 Richard C. Breeden - Director | Grant or award | Director Stock Option (right to buy) | 1,407 | $0.00 | - | |
| Richard C. Breeden - Director | Grant or award | Director Stock Option (right to buy) | 297 | $84.20 | $25K | |
| Richard C. Breeden - Director | Grant or award | Career Restricted Stock Units | 487 | $0.00 | - | |
| Richard C. Breeden - Director | Grant or award | Career Restricted Stock Units | 355 | $242.85 | $86K | |
| Christopher S. Holland - Director | Grant or award | Career Restricted Stock Units | 975 | $0.00 | - | |
 Michael J. Tokich - Officer | Tax withholding / forfeiture | Ordinary Shares | 341 | $242.10 | $83K | |
| Michael J. Tokich - Officer | Grant or award | Ordinary Shares | 2,223 | $0.00 | - | |
| Michael J. Tokich - Officer | Grant or award | Employee Stock Option (right to buy) | 7,908 | $0.00 | - | |
| Michael J. Tokich - Officer | Tax withholding / forfeiture | Ordinary Shares | 386 | $242.08 | $93K | |
| Michael J. Tokich - Officer | Tax withholding / forfeiture | Ordinary Shares | 172 | $242.08 | $42K | |
| Michael J. Tokich - Officer | Tax withholding / forfeiture | Ordinary Shares | 169 | $242.08 | $41K | |
 Cary L. Majors - Officer | Open-market sale | Ordinary Shares | 1,682 | $217.32 | $366K | |
| Julia Madsen - Officer | Tax withholding / forfeiture | Ordinary Shares | 250 | $235.78 | $59K | |
| Renato Tamaro - Officer | Tax withholding / forfeiture | Ordinary Shares | 78 | $235.78 | $18K | |
| Karen L. Burton - Officer | Tax withholding / forfeiture | Ordinary Shares | 26 | $235.78 | $6K | |
| Daniel A. Carestio - Officer | Tax withholding / forfeiture | Ordinary Shares | 130 | $235.78 | $31K | |
| John Adam Zangerle - Officer | Tax withholding / forfeiture | Ordinary Shares | 91 | $235.78 | $21K | |
| Michael J. Tokich - Officer | Tax withholding / forfeiture | Ordinary Shares | 194 | $235.78 | $46K |
Recent STE Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| Breeden Richard C | Director | 4,110 | $953K | View on EDGAR | |
| Sohi Mohsen | Director | 4,058 | $957K |
Stock trades in STE disclosed by members of the U.S. House in the last 12 months, newest first. Values are the ranges as filed.
| Member | Type | Traded | Disclosed | Value range | Owner | Days to disclose | Filing |
|---|---|---|---|---|---|---|---|
 Kevin HernRepublican, OK-01 | Sale |
STE insider trading FAQ
What is the latest insider trade for STE?
STERIS plc (STE) had 9 insider filings in the last 90 days, with the most recent on 2026-10-05. The full record for STE runs to 78 Form 4 filings, the earliest from 2024-10-02. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying STE stock?
No insider purchases of STE were filed in the last 90 days.
How many insiders are selling STE stock?
1 insider sale of STE was filed in the last 90 days, totaling $957K.
Where can I see STE SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects STE Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Karen L. Burton view on EDGAR
- - Mohsen Sohi view on EDGAR
- - Louis Shapiro view on EDGAR
- - Nirav R. Shah view on EDGAR
- - Paul Edward Martin view on EDGAR
- - Christopher S. Holland view on EDGAR
- - Cynthia L. Feldmann view on EDGAR
- - Pierre Boulud view on EDGAR
- - Esther M. Alegria view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where STE's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow STE with a 7-day demo
- STE on your watchlist
- Every STE Form 4 filing on record
- Up to 3 months of STE price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
